Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease (2010)
- Authors:
- USP affiliated authors: SILVA, MARCELO NUNES - IQ ; ZINGALES, BIANCA SILVANA - IQ
- Unidade: IQ
- DOI: 10.1590/s0074-02762010000700014
- Subjects: TRYPANOSOMA CRUZI; DOENÇA DE CHAGAS
- Language: Inglês
- Imprenta:
- Publisher place: Rio de Janeiro
- Date published: 2010
- Source:
- Título: Memórias do Instituto Oswaldo Cruz
- ISSN: 0074-0276
- Volume/Número/Paginação/Ano: v. 105, n. 7, 918-924, 2010
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MORENO, Margoth Mitchela Vigo et al. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease. Memórias do Instituto Oswaldo Cruz, v. 105, n. 7, 2010Tradução . . Disponível em: https://doi.org/10.1590/s0074-02762010000700014. Acesso em: 26 jan. 2026. -
APA
Moreno, M. M. V., D'Ávila, D. A., Silva, M. N. da, Galvão, L. M. da C., Macedo, A. M., Chiari, E., et al. (2010). Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease. Memórias do Instituto Oswaldo Cruz, 105( 7). doi:10.1590/s0074-02762010000700014 -
NLM
Moreno MMV, D'Ávila DA, Silva MN da, Galvão LM da C, Macedo AM, Chiari E, Gontijo ED, Zingales B. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease [Internet]. Memórias do Instituto Oswaldo Cruz. 2010 ; 105( 7):[citado 2026 jan. 26 ] Available from: https://doi.org/10.1590/s0074-02762010000700014 -
Vancouver
Moreno MMV, D'Ávila DA, Silva MN da, Galvão LM da C, Macedo AM, Chiari E, Gontijo ED, Zingales B. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease [Internet]. Memórias do Instituto Oswaldo Cruz. 2010 ; 105( 7):[citado 2026 jan. 26 ] Available from: https://doi.org/10.1590/s0074-02762010000700014 - Designing and exploring active N '-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients
- Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds
- Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo
- 24s alfa ribosomal rna as target for the detection of trypanosoma cruzi
- Polymorphism in a 24s alfa ribosomal rna region from strains of trypanosoma cruzi
- Ribossomal rna as a target for the detection of trypanosoma cruzi
- Potential use of 24s 'ALPHA' ribosomal rna as a target for the detection of trypanosoma cruzi
- Divergent domain in trypanosoma cruzi 245 alpha ribosomal rna gene presents sequence dimorphism among strains and allows parasite detection
- Genetic analysis of a divergent domain from the 24s 'ALPHA' ribosomal rna of trypanosoma cruzi
- Microarrays for the analysis of gene expression in strains and developmental stages of Trypanosoma cruzi
Informações sobre o DOI: 10.1590/s0074-02762010000700014 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
